Return to List
Results 1–20 of 21
Title Date
1.

Adolescent Confidentiality and Electronic Health Records

Number 599

Abstract: Confidentiality concerns are heightened during adolescence, and these concerns can be a critical barrier to adolescents in receiving appropriate health care. Health care providers caring fo...

May 2014

PDF Format
2.

Challenges for Overweight and Obese Women

Number 591

(Replaces Committee Opinion Number 470, October 2010)

ABSTRACT: Overweight and obesity are epidemic in the United States. Obesity is a risk factor for numerous conditions, including diabetes, hypertension, high cholesterol, stroke, heart disease, certai...

March 2014

PDF Format
3.

Depot Medroxyprogesterone Acetate and Bone Effects

Number 602

(Replaces Committee Opinion Number 415, September 2008)

ABSTRACT: Depot medroxyprogesterone acetate (DMPA) is a highly effective injectable contraceptive that affords privacy and has a convenient dose schedule of four times per year, making it appealing t...

June 2014

PDF Format
4.

Effective Patient–Physician Communication

Number 587

(Replaces Committee Opinion Number 492, May 2011)

ABSTRACT: Physicians’ ability to effectively and compassionately communicate information is key to a successful patient–physician relationship. The current health care environment demands increasing ...

February 2014

PDF Format
5.

Ethical Issues in the Care of the Obese Woman

Number 600

ABSTRACT: Rates of obesity in the United States have increased rapidly over the past several decades, and physicians should be prepared to care for obese patients in a nonjudgmental manner, being cog...

June 2014

PDF Format
6.

Evaluation of Uncomplicated Stress Urinary Incontinence in Women Before Surgical Treatment

Number 603

ABSTRACT: Stress urinary incontinence (SUI) is a condition of involuntary loss of urine on effort, physical exertion, sneezing, or coughing that is often bothersome to the patient and frequently affe...

June 2014

PDF Format
7.

Female Age-Related Fertility Decline

Number 589

(Replaces Committee Opinion Number 413, August 2008)

ABSTRACT: The fecundity of women decreases gradually but significantly beginning approximately at age 32 years and decreases more rapidly after age 37 years. Education and enhanced awareness of the e...

March 2014

PDF Format
8.

Health Disparities in Rural Women

Number 586

(Replaces Committee Opinion Number 429, March 2009)

ABSTRACT: Rural women experience poorer health outcomes and have less access to health care than urban women. Many rural areas have limited numbers of health care providers, especially women’s health...

February 2014

PDF Format
9.

Human Papillomavirus Vaccination

Number 588

(Replaces Committee Opinion Number 467, September 2010)

ABSTRACT: The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends that human papillomavirus (HPV) vaccination routinely be targeted to females an...

March 2014

PDF Format
10.

Immersion in Water During Labor and Delivery

Number 594

ABSTRACT: Immersion in water has been suggested as a beneficial alternative for labor, or delivery, or both and over the past decades has gained popularity in many parts of world. Immersion in water ...

April 2014

PDF Format
11.

Labor Induction or Augmentation and Autism

Number 597

Abstract: Functional oxytocin deficiency and a faulty oxytocin signaling pathway have been observed in conjunction with autism spectrum disorder (ASD). Because exogenous synthetic oxytocin commonly i...

May 2014

PDF Format
12.

Management of Women With Dense Breasts Diagnosed by Mammography

Number 593

ABSTRACT: Women with dense breasts have a modestly increased risk of breast cancer and experience reduced sensitivity of mammography to detect breast cancer. However, evidence is lacking to advocate ...

April 2014

PDF Format
13.

OnabotulinumtoxinA and the Bladder

Number 604

ABSTRACT: In January 2013, the U.S. Food and Drug Administration approved the use of onabotulinumtoxinA (also known as Botox A) for the treatment of overactive bladder, thus providing another treatme...

June 2014

PDF Format
14.

Options for Prevention and Management of Heavy Menstrual Bleeding in Adolescent Patients Undergoing

Number 606

ABSTRACT: Adolescents undergoing cancer treatment are at high risk of heavy menstrual bleeding, and gynecologists may be consulted either before the initiation of cancer treatment to request strategi...

August 2014

PDF Format
15.

Preexposure Prophylaxis for the Prevention of Human Immunodeficiency Virus

Number 595

Abstract: Preexposure prophylaxis is defined as the administration of antiretroviral medications to individuals who are not infected with human immunodeficiency virus (HIV) and are at the highest ris...

May 2014

PDF Format
16.

Preparing for Clinical Emergencies in Obstetrics and Gynecology

Number 590

(Replaces Committee Opinion Number 487, April 2011)

ABSTRACT: Patient care emergencies may occur at any time in any setting, particularly the inpatient setting. It is important that obstetrician–gynecologists prepare themselves by assessing potential ...

March 2014

PDF Format
17.

Primary Ovarian Insufficiency in Adolescents and Young Women

Number 605

ABSTRACT: Primary ovarian insufficiency is the depletion or dysfunction of ovarian follicles with cessation of menses before age 40 years. There is no consensus on criteria to identify primary ovaria...

July 2014

PDF Format
18.

Routine Human Immunodeficiency Virus Screening

Number 596

(Replaces Committee Opinion Number 411, August 2008)

Abstract: Early diagnosis and treatment of human immunodeficiency virus (HIV) can improve survival and reduce morbidity. The Centers for Disease Control and Prevention and the American College of Obs...

May 2014

PDF Format
19.

Sexual Assault

Number 592

(Replaces Committee Opinion Number 499, August 2011)

ABSTRACT: Reproductive-aged victims of sexual assault are at risk of unintended pregnancy, sexually transmitted infections, and mental health conditions, including posttraumatic stress disorder. Heal...

April 2014

PDF Format
20.

Tamoxifen and Uterine Cancer

Number 601

(Replaces Committee Opinion Number 336, June 2006)

ABSTRACT: Tamoxifen, a nonsteroidal antiestrogen agent, is widely used as adjunctive therapy for women with breast cancer, and it has been approved by the U.S. Food and Drug Administration for adjuva...

June 2014

PDF Format